This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.
Wooden wind turbines promise to significantly reduce CO2 emissions during construction and production costs compared to current turbine blades. Designed and manufactured by Voodin Blade Technology, a German pioneer in wind turbine blade manufacturing, the laminated veneer lumber blades are a more sustainable construction material than current materials and allow for easier recycling of decommissioned blades.
The Teal Wand is an at-home self-collect device that aims to improve rates of screenings and provide a comfortable and accessible alternative to traditional pap smears. The U.S. Food and Drug Administration has now granted the Teal Wand with Breakthrough Device status; a designation awarded to medical devices that the FDA considers “life-saving” or “life-changing.”
In 2021, the world’s first large-scale carbon removal plant started sucking CO2 from the air in a remote corner of Iceland. Now Climeworks, the company behind it, has opened a version that’s ten times larger. The new plant, called Mammoth, has installed 12 modular containers so far. By the end of the year, it will have 72, with the capacity to capture around 36,000 tons of CO2 per year.
Synthetic opioids are one of the main drivers in overdose deaths in the United States. They are often mixed with other drugs, but because of their potency, they are often present in such small amounts that they can be hard to detect. The new sensor, developed by researchers at the University of Pittsburgh, uses carbon nanotubes and gold nanoparticles to tell the most deadly drugs apart from others.
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
In a first-ever human clinical trial of adult patients, an mRNA cancer vaccine developed at the University of Florida reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor. The results mirror those in 10 pet dog patients suffering from brain tumors, as well as results from preclinical mouse models. The breakthrough will now be tested in a Phase 1 pediatric clinical trial.
There’s a global shortage of blood supplies needed for life-saving transfusions due to factors that include an aging population with a higher demand for it and a lack of volunteer donors. To help address this challenge, researchers at the Technical University of Denmark (DTU) and Lund University, Sweden, have used enzymes produced by a common gut bacteria to remove the A and B antigens from red blood cells, bringing them one step closer to creating universal donor blood.
New mosquito bed nets cut malaria transmission by 20 to 50 percent in a major trial across 17 African countries, offering a real answer to the growing problem of insecticide resistance. The nets pair the standard pyrethroid coating with a second insecticide that hits mosquitoes through a different biological pathway, so the ones that used to shrug off treated nets no longer can. At under three dollars each, they cost about the same as the older versions they’re replacing. Paired with the malaria vaccine now rolling out across Africa, these nets are part of a layered defense that could meaningfully shift the trajectory of a disease that still kills hundreds of thousands of people every year.
Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization has announced. The Men5CV vaccine offers a powerful shield against the five major strains of the meningococcal bacteria that cause the disease. Known by the brand name MenFive, it provides broader protection than the vaccine currently used in much of Africa.
Scientists from the University of Surrey in England, working with colleagues at the University of Cambridge, the Chinese Academy of Sciences, Xidian University, and Zhengzhou University, have developed a flexible perovskite solar panel that use electrodes made of tiny carbon nanotubes. The researchers demonstrated that in addition to producing more energy than traditional solar panels, “the material cost of an all-carbon-electrode-based bifacial PSC is about 70% lower than that of a monofacial device.”
The City of Liverpool, England, has unveiled advanced proposals to build the world’s largest tidal power generator on the River Mersey. Mersey Tidal Power would become the largest tidal range scheme in the world. It would power more than 1 million homes for more than 120 years.
